drugset / Trial / NCT00972257

24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination

NCT00972257

Phase 4 Completed 64 enrolled Aristotle University Of Thessaloniki
RandomizedCrossoverSingle-blindTreatment

Summary

The proposed study will compare for the first time the quality of 24-hour IOP control with Brimonidine/Timolol fixed combination (BTFC) versus Dorzolamide/Timolol fixed combination (DTFC) after a run-in period of 2 months with timolol. This crossover comparison may determine the real efficacy of the two fixed combinations and the design of the proposed study may explain for the first time why the 24-hour IOP reduction provided by BTFC is less than might be anticipated.

Timeline

Start
2009-01
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule
Comparator Dorzolamide Small molecule
Comparator Timolol Other / unclassified

Indications